Silo Pharma (SILO) Preferred Stock Liabilities (2017 - 2020)
Silo Pharma (SILO) posted Preferred Stock Liabilities of $400000.0 for Q2 2020, little changed sequentially from $400000.0 in Q1 2020, and little changed YoY from $400000.0 in Q3 2019.
Silo Pharma (SILO) Preferred Stock Liabilities (2017 - 2020) Analysis & Trends
Silo Pharma has reported Preferred Stock Liabilities for 4 years, with the latest figure at $400000.0 in Q2 2020.
- Quarterly Preferred Stock Liabilities changed 0.0% year-over-year to $400000.0 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $400000.0 (changed 0.0% YoY) and the FY2019 annual result came in at $400000.0, changed 0.0% from the prior year.
- Preferred Stock Liabilities held at $400000.0 in Q2 2020 per SILO's latest filing, from $400000.0 in the prior quarter.
- Over five years, Preferred Stock Liabilities peaked at $400000.0 in Q4 2017 and troughed at $400000.0 in Q4 2017.
- A 4-year average of $400000.0 and a median of $400000.0 in 2017 frame the typical range for Preferred Stock Liabilities.
- The widest YoY moves for Preferred Stock Liabilities: up 0.0% in 2018, down 0.0% in 2018.
- Over 4 years, Preferred Stock Liabilities stood at $400000.0 in 2017, then changed by 0.0% to $400000.0 in 2018, then changed by 0.0% to $400000.0 in 2019, then changed by 0.0% to $400000.0 in 2020.
- According to Business Quant data, Preferred Stock Liabilities over the past three periods registered $400000.0, $400000.0, and $400000.0 for Q2 2020, Q1 2020, and Q4 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Silo Pharma | 2.92 Mn | 2.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 400,000.00 |
| Mar 31, 2020 | 400,000.00 |
| Dec 31, 2019 | 400,000.00 |
| Sep 30, 2019 | 400,000.00 |
| Jun 30, 2019 | 400,000.00 |
| Mar 31, 2019 | 400,000.00 |
| Dec 31, 2018 | 400,000.00 |
| Sep 30, 2018 | 400,000.00 |
| Dec 31, 2017 | 400,000.00 |